| Advanced and Metastatic Breast Cancer |
1 |
1 |
| Biologic Therapy |
0 |
1 |
| Breast Cancer |
0 |
0.9 |
| HER2-Positive Breast Cancer |
0 |
0.85 |
| Estrogen Receptor-Positive (ER+) Breast Cancer |
0 |
0.85 |
| Antineoplastic Drug |
0 |
0.7 |
| Surgery |
0 |
0.65 |
| Breast Surgery |
0 |
0.85 |
| Humanized Monoclonal Antibody |
0 |
0.52 |
| Genomic Medicine |
0 |
0.55 |
| Cancer |
0 |
0.26 |
| Radiation Therapy |
0 |
0.26 |
| Breast |
0 |
0.2 |
| Tumor |
0 |
0.2 |
| Epidermal Growth Factor Receptor |
0 |
0.14 |
| Chemotherapy |
0 |
0.65 |
| Neoadjuvant Therapy |
0 |
0.13 |
| Receptors |
0 |
0.13 |
| Endocrine Therapy |
0 |
0.85 |
| Residual Disease |
0 |
0.07 |